Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Organogenesis Holdings Inc (ORGO)

Organogenesis Holdings Inc (ORGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 288,156
  • Shares Outstanding, K 128,641
  • Annual Sales, $ 564,170 K
  • Annual Income, $ 37,030 K
  • EBIT $ 45 M
  • EBITDA $ 72 M
  • 60-Month Beta 1.48
  • Price/Sales 0.53
  • Price/Cash Flow 3.57
  • Price/Book 0.98

Options Overview Details

View History
  • Implied Volatility 245.41% (+144.47%)
  • Historical Volatility 58.87%
  • IV Percentile 71%
  • IV Rank 28.09%
  • IV High 662.58% on 02/10/26
  • IV Low 82.42% on 03/26/26
  • Expected Move (DTE 13) 0.47 (20.87%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 35
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 1,863
  • Open Int (30-Day) 1,948
  • Expected Range 1.77 to 2.71

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-0.13
  • Growth Rate Est. (year over year) +768,561.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.21 +1.36%
on 04/02/26
3.02 -25.83%
on 03/05/26
-0.76 (-25.33%)
since 03/02/26
3-Month
2.21 +1.36%
on 04/02/26
4.66 -51.91%
on 01/05/26
-2.40 (-51.67%)
since 01/02/26
52-Week
2.21 +1.36%
on 04/02/26
7.08 -68.35%
on 11/11/25
-2.11 (-48.51%)
since 04/02/25

Most Recent Stories

More News
Organogenesis: Q4 Earnings Snapshot

Organogenesis: Q4 Earnings Snapshot

ORGO : 2.24 (-3.03%)
Organogenesis Holdings Inc. Reports Fourth Quarter 2025 Financial Results, Posts Record Revenue

CANTON, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine and tissue innovations company focused on empowering healing through the development,...

ORGO : 2.24 (-3.03%)
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026

CANTON, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product...

ORGO : 2.24 (-3.03%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO

NEW YORK , Jan. 29, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO). Such investors...

ORGO : 2.24 (-3.03%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO

NEW YORK , Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO). Such investors...

ORGO : 2.24 (-3.03%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO

NEW YORK , Jan. 15, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO). Such investors...

ORGO : 2.24 (-3.03%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO

NEW YORK , Jan. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO). Such investors...

ORGO : 2.24 (-3.03%)
Organogenesis Announces Initiation of Biologics License Application for ReNu®

CANTON, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product...

ORGO : 2.24 (-3.03%)
Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain

Clinical Development Program Appropriate for Rolling BLA  Submission Expected by the End of 2025 CANTON, Mass., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO),...

ORGO : 2.24 (-3.03%)
Organogenesis: Q3 Earnings Snapshot

Organogenesis: Q3 Earnings Snapshot

ORGO : 2.24 (-3.03%)

Business Summary

Organogenesis is a leading regenerative medicine company focused on the development, manufacture and commercialization of solutions for the Advanced Wound Care and Surgical & Sports Medicine markets.

See More

Key Turning Points

3rd Resistance Point 2.36
2nd Resistance Point 2.33
1st Resistance Point 2.28
Last Price 2.24
1st Support Level 2.20
2nd Support Level 2.17
3rd Support Level 2.12

See More

52-Week High 7.08
Fibonacci 61.8% 5.22
Fibonacci 50% 4.64
Fibonacci 38.2% 4.07
Last Price 2.24
52-Week Low 2.21

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.